6-hydroxytryptamine has been researched along with Malignant Melanoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawano, Y; Yamazaki, Y | 1 |
1 other study(ies) available for 6-hydroxytryptamine and Malignant Melanoma
| Article | Year |
|---|---|
N-(3,5-dihydroxybenzoyl)-6-hydroxytryptamine as a novel human tyrosinase inhibitor that inactivates the enzyme in cooperation with l-3,4-dihydroxyphenylalanine.
Topics: Cell Line, Tumor; Enzyme Inhibitors; Humans; Levodopa; Melanoma; Monophenol Monooxygenase; Serotonin | 2010 |